# A Study of Eltrekibart (LY3041658) in Healthy Participants

> **NCT07545590** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3041658
- **DRUG:** LY3041658

## Key facts

- **NCT ID:** NCT07545590
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07545590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07545590, "A Study of Eltrekibart (LY3041658) in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07545590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*